Anup Shah joins Woolley Pau PR
June 25, 2010Medical Communications Woolley Pau, appointment, medical communications
Anup Shah has joined Woolley Pau PR as account director to develop the UK agency’s PR’s medical communication team. He …
Sanofi licences novel oral anti-diabetic treatment
June 25, 2010Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes
Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …
NICE re-thinks arthritis guidance
June 25, 2010Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis
NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …
Digital Pharma: First pharma iPad apps
June 25, 2010Medical Communications, Sales and Marketing Apple, Pfizer, Sanofi, app, ipad, iphone
The first big pharma apps specially designed for Apple’s iPad have started to emerge, with Pfizer and Sanofi leading the …
WPP forms largest healthcare coms network
June 25, 2010Medical Communications CommonHealth, Ogilvy, WPP, ogilvy healthworld advertising
Global communications giant WPP has merged its Ogilvy Healthworld and CommonHealth businesses. Named Ogilvy CommonHealth Worldwide, the new entity becomes …
Merck moves tropical disease drug into phase II
June 25, 2010Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease
Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …
Clavis Pharma appoints Athos Gianella-Borradori
June 24, 2010Research and Development Clavis Pharma, appointment, research and development
Athos Gianella-Borradori has joined clinical stage oncology drug development company Clavis Pharma as chief medical officer. His appointment to the …
NICE rejects Glivec as adjuvant therapy
June 24, 2010Sales and Marketing Glivec, NICE, Novartis
NICE has rejected the use of Novartis’ Glivec as an adjuvant treatment for people who have had a gastrointestinal stromal …
AstraZeneca and Targacept begin depression trials
June 24, 2010Research and Development AstraZeneca, Targacept, depression
AstraZeneca and Targacept have begun enrolling patients in phase III trials for TC-5214, a new treatment for depression. The new …
CME Spotlight: Coalition politics in European CME
June 24, 2010Medical Communications CME, CME Spotlight
The election is now over and rather than the damp squib that I foresaw, it feels like something new and …
Prix Galien shortlist unveiled
June 24, 2010Research and Development prix galien
The shortlist of innovative medicines which will compete for two prestigious UK Prix Galien medals later this year has been …
Pfizer plant cleared by FDA to make NicOx drug
June 24, 2010Manufacturing and Production Capsugel, NicOx, Pfizer, manufacturing, naproxcinod
Pfizer subsidiary Capsugel has won approval from the US Food and Drug Administration for a manufacturing facility based in France …
Digital Pharma: Playing healthcare games
June 23, 2010Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games
Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …
Plans for UK’s research hub unveiled
June 23, 2010Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome, biomedical
The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …
Prosensa and GSK add to muscular dystrophy alliance
June 23, 2010Research and Development GlaxoSmithKline, Prosensa, muscular dystrophy
GSK has extended its research alliance with biotech company Prosensa in the field of muscular dystrophy. Netherlands-based Prosensa focuses on …
Mixed reaction for Osborne’s first Budget
June 23, 2010Research and Development, Sales and Marketing biotech, pharma, tax, tax relief
George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
Congress summons J&J chief executive
June 23, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …
PRA bolsters late phase services
June 23, 2010Research and Development CRO, PRA, appointment, research and development
Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business. Late Phase Services …
Sanofi signs microRNA therapy deal
June 23, 2010Research and Development RNA, Regulus, Sanofi-Aventis
Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …
Medical Affairs at the Centre of Life Sciences Innovation
June 22, 2010Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf
In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
